Attorney Genese Dopson will recap the Wyeth decision and recent state court decisions and discuss how Wyeth has impacted―and likely will continue to impact―generic drug manufacturers. This webinar will also examine:

Genese K. Dopson, J.D., is a Partner in the San Francisco office of Wilson Elser Moskowitz Edelman & Dicker LLP. She is a former Oncology Head Nurse and her practice focuses on the defense of pharmaceutical and medical device manufacturers, as well as personal injury and employment discrimination matters.

During her career, Genese has served as national coordinating counsel and managed litigation for pharmaceutical and medical device manufacturers in multi plaintiffs / multi state litigation. She is currently national coordinating counsel in the defense of a brand manufacturer in the quinine litigation. She has represented both brand and generic pharmaceutical companies and has defended a wide variety of medical device manufacturers.

Genese was designated Medmarc Insurance Company's Defense Attorney of the Year in 2005. She served on the editorial advisory board of MX Magazine, a publication that served the medical device industry.